Sucheta Das

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Topoisomerase-I (TOP-I) has emerged as a potential target for the design and development of anticancer compounds. TOP-I inhibitors have shown promise in the treatment of various cancers including renal cell cancer, whose exact cause is yet to be known. Recent studies indicate that indenoisoquinolines can provide greater stability to drug-topoisomerase-DNA(More)
  • 1